Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Older periods Mar '24 Jun '24 Sep '24 Dec '24
Piotroski F-Score

+8 more TTM periods

2 — — 3
ROE
(237.28%) (254.45%) (391.52%) 153.11%
ROA
(84.95%) (72.97%) (71.70%) (23.11%)
ROIC
(41.26%) (16.32%) (9.84%) (0.51%)
Return on Tangible Assets
(263.92%) (293.34%) (316.75%) (69.91%)
Average Days of Receivables
296.30 277.22 236.84 142.65
Free Cash Flow per Share
(2.18) (1.87) (1.50) (1.07)
Free Cash Flow
(64.62) (55.51) (44.79) (31.77)
Capital Expenditures
(0.30) 0.42 0.82 (0.11)
Other line items
Cash ROIC
(127.81%) (136.36%) (129.28%) (90.79%)
Accounts Receivable Turnover
1.46 1.44 1.62 2.10
Accounts Payable Turnover
2.71 3.84 4.80 9.48
Inventory Turnover
1.14 1.32 1.56 6.31
Average Days of Payables
97.53 44.55 40.21 24.33
Days of Inventory on Hand
181.44 138.00 98.49 34.13
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 20.92% 10.59% 0.00%
Selling, General and Administrative Expense of Revenue
135.45% 97.67% 77.06% 51.77%
Share Based Compensation of Revenue
27.74% 19.25% 14.44% 2.28%
Interest Coverage
(1.21) (0.62) (0.25) (0.01)
Operating CF/Net income
0.96 1.13 1.09 3.32
Depreciation/Fixed assets
0.61 1.31 1.80 3.73
Capex/Depreciation
(0.59) 0.39 0.62 (0.06)
Revenue per Share
0.32 0.41 0.52 0.68
Operating CF per Share
(2.17) (1.88) (1.53) (1.06)
Capex per Share
(0.01) 0.01 0.03 0.00
Capex to Sales
0.03 (0.03) (0.05) 0.01

Fold the line items

Columns are period end dates